VALGANCICLOVIR is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Valganciclovir Hydrochloride.
Product ID | 31722-837_eaad537e-d8e5-24a2-e053-2a95a90ad075 |
NDC | 31722-837 |
Product Type | Human Prescription Drug |
Proprietary Name | VALGANCICLOVIR |
Generic Name | Valganciclovir Hydrochloride |
Dosage Form | Powder, For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-10-04 |
Marketing Category | ANDA / |
Application Number | ANDA211475 |
Labeler Name | Camber Pharmaceuticals, Inc. |
Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-10-04 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0603-6330 | Valganciclovir | Valganciclovir hydrochloride |
0904-6796 | Valganciclovir | Valganciclovir |
16714-765 | Valganciclovir | Valganciclovir |
27241-158 | Valganciclovir | Valganciclovir |
31722-832 | Valganciclovir | Valganciclovir |
31722-837 | VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE |
42291-875 | Valganciclovir | Valganciclovir hydrochloride |
48433-124 | Valganciclovir | Valganciclovir |
50268-787 | Valganciclovir | Valganciclovir |
68084-965 | Valganciclovir | Valganciclovir |
69097-277 | Valganciclovir | Valganciclovir |
55111-762 | Valganciclovir | Valganciclovir |
60429-846 | Valganciclovir | Valganciclovir |
0004-0038 | Valcyte | valganciclovir |
0004-0039 | Valcyte | valganciclovir hydrochloride |
27241-159 | Valganciclovir hydrochloride | Valganciclovir hydrochloride |
43598-356 | valganciclovir hydrochloride | valganciclovir hydrochloride |
0591-2579 | Valganciclovir hydrochloride for Oral | Valganciclovir hydrochloride |